(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PLK2 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1348089 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLK2 mRNA CTD PMID:22079256 (S)-nicotine increases expression ISO RGD:733048 6480464 Nicotine results in increased expression of PLK2 mRNA CTD PMID:17456735 1,1-dichloroethene increases expression ISO RGD:733048 6480464 vinylidene chloride results in increased expression of PLK2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of PLK2 mRNA CTD PMID:27840820 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of PLK2 mRNA CTD PMID:22841810 17alpha-ethynylestradiol affects expression ISO RGD:733048 6480464 Ethinyl Estradiol affects the expression of PLK2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of PLK2 mRNA CTD PMID:16174780 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PLK2 mRNA CTD PMID:17351261 17beta-estradiol increases expression ISO RGD:733048 6480464 Estradiol results in increased expression of PLK2 mRNA CTD PMID:25210133 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PLK2 mRNA CTD PMID:32145629 17beta-estradiol affects expression ISO RGD:1348089 6480464 Estradiol affects the expression of PLK2 mRNA CTD PMID:14699072 , PMID:22574217 17beta-estradiol decreases expression ISO RGD:1348089 6480464 Estradiol results in decreased expression of PLK2 mRNA CTD PMID:16202921 more ... 17beta-estradiol multiple interactions ISO RGD:1348089 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of PLK2 mRNA more ... CTD PMID:20404318 more ... 17beta-estradiol affects expression ISO RGD:733048 6480464 Estradiol affects the expression of PLK2 mRNA CTD PMID:15598610 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1348089 6480464 Dihydrotestosterone results in increased expression of PLK2 mRNA CTD PMID:29581250 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:1348089 6480464 2 more ... CTD PMID:36804509 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733048 6480464 [Tetrachlorodibenzodioxin affects the methylation of PLK2 intron] which results in increased expression of PLK2 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PLK2 promoter] CTD PMID:19654925 , PMID:33017471 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLK2 mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733048 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLK2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733048 6480464 Tetrachlorodibenzodioxin affects the expression of PLK2 mRNA CTD PMID:16962184 , PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PLK2 mRNA CTD PMID:22298810 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of PLK2 mRNA CTD PMID:21346803 2-acetamidofluorene increases expression ISO RGD:733048 6480464 2-Acetylaminofluorene results in increased expression of PLK2 mRNA CTD PMID:21607683 2-butoxyethanol increases expression ISO RGD:733048 6480464 n-butoxyethanol results in increased expression of PLK2 mRNA CTD PMID:19812364 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:733048 6480464 tetrabromobisphenol A results in increased expression of PLK2 mRNA CTD PMID:25172293 3,4-dichloroaniline decreases expression ISO RGD:1348089 6480464 3, 4-dichloroaniline results in decreased expression of PLK2 mRNA CTD PMID:24172598 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733048 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLK2 mRNA CTD PMID:16054899 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PLK2 mRNA CTD PMID:23052194 4-hydroxynon-2-enal increases expression ISO RGD:733048 6480464 4-hydroxy-2-nonenal results in increased expression of PLK2 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:733048 6480464 Fenretinide results in increased expression of PLK2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:1348089 6480464 Decitabine results in increased expression of PLK2 mRNA CTD PMID:23300844 5-fluorouracil increases expression ISO RGD:1348089 6480464 Fluorouracil results in increased expression of PLK2 mRNA CTD PMID:17982676 5-fluorouracil multiple interactions ISO RGD:1348089 6480464 TP53 protein affects the reaction [Fluorouracil results in increased expression of PLK2 mRNA], TP53 protein promotes the reaction [Fluorouracil results in increased expression of PLK2 mRNA] CTD PMID:15016801 , PMID:17982676 6-O-methylguanine multiple interactions ISO RGD:1348089 6480464 [O(6)-benzylguanine co-treated with O-(6)-methylguanine] results in decreased expression of PLK2 mRNA CTD PMID:29666243 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:12376462 7,12-dimethyltetraphene increases expression IEP 2292404 DMBA increases expression of Plk2 mRNA and protein in rat mammary gland RGD 7,12-dimethyltetraphene increases expression ISO RGD:733048 6480464 9 more ... CTD PMID:32553695 acetamide increases expression EXP 6480464 acetamide results in increased expression of PLK2 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of PLK2 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:733048 6480464 Acrylamide results in decreased expression of PLK2 mRNA CTD PMID:30807115 aflatoxin B1 affects expression ISO RGD:1348089 6480464 Aflatoxin B1 affects the expression of PLK2 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1348089 6480464 Aflatoxin B1 results in increased expression of PLK2 mRNA CTD PMID:21632981 more ... aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PLK2 mRNA CTD PMID:22484513 more ... aflatoxin B1 increases expression ISO RGD:733048 6480464 Aflatoxin B1 results in increased expression of PLK2 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:1348089 6480464 Tretinoin results in increased expression of PLK2 mRNA CTD PMID:17431108 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PLK2 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:1348089 6480464 Antirheumatic Agents results in increased expression of PLK2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1348089 6480464 aristolochic acid I results in decreased expression of PLK2 mRNA, aristolochic acid I results in decreased expression of PLK2 protein CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:733048 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of PLK2 mRNA CTD PMID:23650126 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLK2 mRNA CTD PMID:33854195 benzene increases expression ISO RGD:733048 6480464 Benzene results in increased expression of PLK2, Benzene results in increased expression of PLK2 mRNA CTD PMID:12928149 , PMID:15935813 benzene increases expression ISO RGD:1348089 6480464 Benzene results in increased expression of PLK2 mRNA CTD PMID:19162166 benzene multiple interactions ISO RGD:733048 6480464 TRP53 protein promotes the reaction [Benzene results in increased expression of PLK2] CTD PMID:15935813 benzo[a]pyrene increases expression ISO RGD:733048 6480464 Benzo(a)pyrene results in increased expression of PLK2 mRNA CTD PMID:19770486 more ... benzo[a]pyrene multiple interactions ISO RGD:733048 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK2 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:1348089 6480464 Benzo(a)pyrene results in increased expression of PLK2 mRNA CTD PMID:17879257 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:1348089 6480464 7 more ... CTD PMID:26238291 benzo[b]fluoranthene increases expression ISO RGD:733048 6480464 benzo(b)fluoranthene results in increased expression of PLK2 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:733048 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK2 mRNA CTD PMID:27858113 Benzo[k]fluoranthene increases expression ISO RGD:733048 6480464 benzo(k)fluoranthene results in increased expression of PLK2 mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of PLK2 mRNA CTD PMID:15651846 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PLK2 mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PLK2 mRNA CTD PMID:32145629 bisphenol A increases expression ISO RGD:1348089 6480464 bisphenol A results in increased expression of PLK2 mRNA CTD PMID:27685785 butan-1-ol multiple interactions ISO RGD:1348089 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLK2 mRNA CTD PMID:29432896 butanal increases expression ISO RGD:1348089 6480464 butyraldehyde results in increased expression of PLK2 mRNA CTD PMID:26079696 cadmium dichloride increases expression ISO RGD:1348089 6480464 Cadmium Chloride results in increased expression of PLK2 mRNA CTD PMID:26472689 calciol increases expression ISO RGD:733048 6480464 Cholecalciferol results in increased expression of PLK2 mRNA CTD PMID:16508948 cannabidiol increases expression ISO RGD:733048 6480464 Cannabidiol results in increased expression of PLK2 mRNA CTD PMID:21542829 carbamazepine affects expression ISO RGD:1348089 6480464 Carbamazepine affects the expression of PLK2 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:733048 6480464 Nanotubes, Carbon results in decreased expression of PLK2 mRNA CTD PMID:25554681 carbonyl sulfide decreases expression EXP 6480464 carbonyl sulfide results in decreased expression of PLK2 mRNA CTD PMID:19395590 chloroprene decreases expression ISO RGD:733048 6480464 Chloroprene results in decreased expression of PLK2 mRNA CTD PMID:23125180 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLK2 mRNA CTD PMID:33854195 chlorpyrifos increases expression ISO RGD:733048 6480464 Chlorpyrifos results in increased expression of PLK2 mRNA CTD PMID:37019170 chromium(6+) affects expression ISO RGD:733048 6480464 chromium hexavalent ion affects the expression of PLK2 mRNA CTD PMID:28472532 chromium(6+) affects expression ISO RGD:1348089 6480464 chromium hexavalent ion affects the expression of PLK2 mRNA CTD PMID:30690063 chrysene multiple interactions ISO RGD:733048 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK2 mRNA CTD PMID:27858113 ciguatoxin CTX1B affects expression ISO RGD:733048 6480464 Ciguatoxins affects the expression of PLK2 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:733048 6480464 Cisplatin results in increased expression of PLK2 mRNA, Cisplatin results in increased expression of PLK2 protein CTD PMID:25270620 , PMID:35842499 cisplatin multiple interactions ISO RGD:733048 6480464 NFE2L2 protein affects the reaction [Cisplatin results in increased expression of PLK2 mRNA] CTD PMID:35842499 cisplatin affects localization EXP 6480464 Cisplatin affects the localization of PLK2 protein CTD PMID:35842499 cisplatin multiple interactions EXP 6480464 Cisplatin promotes the reaction [NFE2L2 protein modified form binds to PLK2 protein] more ... CTD PMID:35842499 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of PLK2 mRNA, Cisplatin results in increased expression of PLK2 protein CTD PMID:35842499 cisplatin increases expression ISO RGD:1348089 6480464 Cisplatin results in increased expression of PLK2 mRNA CTD PMID:21532991 , PMID:23300844 clobetasol increases expression ISO RGD:733048 6480464 Clobetasol results in increased expression of PLK2 mRNA CTD PMID:27462272 clofibrate multiple interactions ISO RGD:733048 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PLK2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PLK2 mRNA] CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:1348089 6480464 cobaltous chloride results in decreased expression of PLK2 mRNA CTD PMID:19320972 copper atom decreases expression EXP 6480464 Copper results in decreased expression of PLK2 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of PLK2 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:1348089 6480464 Copper Sulfate results in increased expression of PLK2 mRNA CTD PMID:19549813 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of PLK2 mRNA CTD PMID:15755911 coumarin decreases phosphorylation ISO RGD:1348089 6480464 coumarin results in decreased phosphorylation of PLK2 protein CTD PMID:35688186 CU-O LINKAGE decreases expression ISO RGD:1348089 6480464 cupric oxide results in decreased expression of PLK2 mRNA CTD PMID:22077320 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of PLK2 mRNA CTD PMID:26577399 curcumin increases expression ISO RGD:1348089 6480464 Curcumin analog results in increased expression of PLK2 mRNA CTD PMID:26409325 cyclosporin A increases expression ISO RGD:1348089 6480464 Cyclosporine results in increased expression of PLK2 mRNA CTD PMID:25562108 cyclosporin A decreases expression ISO RGD:1348089 6480464 Cyclosporine results in decreased expression of PLK2 mRNA CTD PMID:27989131 cylindrospermopsin increases expression ISO RGD:1348089 6480464 cylindrospermopsin results in increased expression of PLK2 mRNA CTD PMID:24921660 dexamethasone multiple interactions ISO RGD:733048 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLK2 mRNA CTD PMID:16054899 dexamethasone decreases expression ISO RGD:1348089 6480464 Dexamethasone results in decreased expression of PLK2 mRNA CTD PMID:25047013 diazinon affects expression EXP 6480464 Diazinon affects the expression of PLK2 mRNA CTD PMID:22546817 dibenz[a,h]anthracene increases expression ISO RGD:733048 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:733048 6480464 Dibutyl Phthalate results in increased expression of PLK2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PLK2 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:1348089 6480464 dicrotophos results in decreased expression of PLK2 mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of PLK2 mRNA CTD PMID:22546817 dinophysistoxin 1 increases expression ISO RGD:1348089 6480464 dinophysistoxin 1 results in increased expression of PLK2 mRNA CTD PMID:28939011 dioxygen multiple interactions ISO RGD:733048 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLK2 mRNA CTD PMID:30529165 disodium selenite decreases expression ISO RGD:1348089 6480464 Sodium Selenite results in decreased expression of PLK2 mRNA CTD PMID:18175754 disodium selenite increases expression ISO RGD:1348089 6480464 Sodium Selenite results in increased expression of PLK2 mRNA CTD PMID:24383545 diuron decreases expression ISO RGD:1348089 6480464 Diuron metabolite results in decreased expression of PLK2 mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:1348089 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:1348089 6480464 Doxorubicin affects the expression of PLK2 mRNA CTD PMID:29803840 Echimidine multiple interactions ISO RGD:1348089 6480464 [CYP3A4 protein results in increased metabolism of echimidine] which affects the expression of PLK2 mRNA CTD PMID:33884520 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PLK2 mRNA CTD PMID:29391264 ethanol affects splicing ISO RGD:733048 6480464 Ethanol affects the splicing of PLK2 mRNA CTD PMID:30319688 etoposide increases expression ISO RGD:1348089 6480464 Etoposide results in increased expression of PLK2 mRNA CTD PMID:21527772 ferric oxide increases expression ISO RGD:733048 6480464 ferric oxide analog results in increased expression of PLK2 mRNA CTD PMID:25086211 ferroheme b increases expression ISO RGD:733048 6480464 Heme metabolite results in increased expression of PLK2 mRNA CTD PMID:19191707 fluoranthene multiple interactions ISO RGD:733048 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of PLK2 mRNA CTD PMID:28329830 fonofos increases methylation ISO RGD:1348089 6480464 Fonofos results in increased methylation of PLK2 promoter CTD PMID:22847954 formaldehyde increases expression ISO RGD:1348089 6480464 Formaldehyde results in increased expression of PLK2 mRNA CTD PMID:17938736 genistein decreases expression ISO RGD:1348089 6480464 Genistein results in decreased expression of PLK2 mRNA CTD PMID:23019147 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PLK2 mRNA CTD PMID:22061828 , PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of PLK2 mRNA CTD PMID:24136188 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLK2 mRNA CTD PMID:33854195 heme b increases expression ISO RGD:733048 6480464 Heme metabolite results in increased expression of PLK2 mRNA CTD PMID:19191707 hydrogen cyanide decreases expression ISO RGD:733048 6480464 Hydrogen Cyanide results in decreased expression of PLK2 mRNA CTD PMID:33914522 hydrogen peroxide affects expression ISO RGD:1348089 6480464 Hydrogen Peroxide affects the expression of PLK2 mRNA CTD PMID:20044591 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of PLK2 mRNA, Hydrogen Peroxide results in increased expression of PLK2 protein CTD PMID:34047419 hydrogen peroxide decreases response to substance EXP 6480464 PLK2 protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:34047419 hydrogen peroxide multiple interactions EXP 6480464 PLK2 protein affects the reaction [Hydrogen Peroxide affects the expression of NFE2L2 protein] more ... CTD PMID:34047419 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLK2 mRNA CTD PMID:33854195 indometacin decreases expression ISO RGD:1348089 6480464 Indomethacin results in decreased expression of PLK2 mRNA CTD PMID:16984733 irinotecan increases expression ISO RGD:1348089 6480464 Irinotecan metabolite results in increased expression of PLK2 mRNA, Irinotecan results in increased expression of PLK2 mRNA CTD PMID:15956246 iron(III) nitrilotriacetate increases expression EXP 6480464 ferric nitrilotriacetate results in increased expression of PLK2 mRNA CTD PMID:23208426 isobutanol multiple interactions ISO RGD:1348089 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLK2 mRNA CTD PMID:29432896 L-ascorbic acid decreases expression EXP 6480464 Ascorbic Acid results in decreased expression of PLK2 mRNA CTD PMID:15372504 Lasiocarpine multiple interactions ISO RGD:1348089 6480464 [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of PLK2 mRNA CTD PMID:33884520 leflunomide increases expression ISO RGD:1348089 6480464 leflunomide results in increased expression of PLK2 mRNA CTD PMID:28988120 Licochalcone B increases expression ISO RGD:1348089 6480464 licochalcone B results in increased expression of PLK2 mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions ISO RGD:1348089 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of PLK2 mRNA CTD PMID:35877022 mercury dibromide increases expression ISO RGD:1348089 6480464 mercuric bromide results in increased expression of PLK2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1348089 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLK2 mRNA CTD PMID:27188386 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of PLK2 mRNA CTD PMID:16507785 metformin increases expression EXP 6480464 Metformin results in increased expression of PLK2 mRNA CTD PMID:31324951 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of PLK2 mRNA CTD PMID:30467583 methotrexate multiple interactions EXP 6480464 PLK2 protein affects the reaction [Methotrexate results in increased expression of NFE2L2 protein] CTD PMID:35842499 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of PLK2 protein CTD PMID:35842499 methoxyacetic acid increases expression ISO RGD:1348089 6480464 methoxyacetic acid results in increased expression of PLK2 mRNA CTD PMID:15103026 methylmercury chloride increases expression ISO RGD:1348089 6480464 methylmercuric chloride results in increased expression of PLK2 mRNA CTD PMID:23179753 more ... methylmercury chloride decreases expression ISO RGD:1348089 6480464 methylmercuric chloride results in decreased expression of PLK2 mRNA CTD PMID:34089799 methylmercury chloride multiple interactions ISO RGD:1348089 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLK2 mRNA CTD PMID:27188386 monocrotaline multiple interactions ISO RGD:1348089 6480464 [CYP3A4 protein results in increased metabolism of Monocrotaline] which affects the expression of PLK2 mRNA CTD PMID:33884520 N-ethyl-N-nitrosourea increases expression ISO RGD:733048 6480464 Ethylnitrosourea results in increased expression of PLK2 mRNA CTD PMID:19100860 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of PLK2 mRNA CTD PMID:16026605 N-nitrosodiethylamine increases expression ISO RGD:733048 6480464 Diethylnitrosamine results in increased expression of PLK2 mRNA CTD PMID:19100860 , PMID:21607683 N-Nitrosopyrrolidine increases expression ISO RGD:1348089 6480464 N-Nitrosopyrrolidine results in increased expression of PLK2 mRNA CTD PMID:32234424 naphthalenes increases expression EXP 6480464 Naphthalenes results in increased expression of PLK2 protein CTD PMID:17337753 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of PLK2 mRNA CTD PMID:22546817 nickel sulfate decreases expression ISO RGD:1348089 6480464 nickel sulfate results in decreased expression of PLK2 mRNA CTD PMID:22714537 nicotine increases expression ISO RGD:733048 6480464 Nicotine results in increased expression of PLK2 mRNA CTD PMID:17456735 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of PLK2 mRNA CTD PMID:23208426 , PMID:23358140 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of PLK2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PLK2 mRNA CTD PMID:25729387 ozone increases expression EXP 6480464 Ozone results in increased expression of PLK2 mRNA CTD PMID:28623178 ozone increases expression ISO RGD:1348089 6480464 Ozone results in increased expression of PLK2 mRNA CTD PMID:23033980 p-chloromercuribenzoic acid increases expression ISO RGD:1348089 6480464 p-Chloromercuribenzoic Acid results in increased expression of PLK2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1348089 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLK2 mRNA CTD PMID:27188386 paracetamol multiple interactions ISO RGD:733048 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PLK2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PLK2 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PLK2 mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:733048 6480464 Acetaminophen affects the expression of PLK2 mRNA CTD PMID:17562736 parathion increases methylation ISO RGD:1348089 6480464 Parathion results in increased methylation of PLK2 promoter CTD PMID:22847954 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of PLK2 mRNA CTD PMID:18692542 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1348089 6480464 perfluorooctane sulfonic acid results in increased expression of PLK2 mRNA CTD PMID:27153767 phenobarbital affects expression ISO RGD:1348089 6480464 Phenobarbital affects the expression of PLK2 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:1348089 6480464 Phenylmercuric Acetate results in increased expression of PLK2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1348089 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLK2 mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of PLK2 mRNA CTD PMID:12376462 PhIP increases expression IEP 2292404 PhIP increases expression of Plk2 mRNA and protein in rat mammary gland RGD pirinixic acid multiple interactions ISO RGD:1348089 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLK2 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:733048 6480464 pirinixic acid results in increased expression of PLK2 mRNA CTD PMID:18301758 potassium chromate multiple interactions ISO RGD:1348089 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLK2 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1348089 6480464 potassium chromate(VI) results in increased expression of PLK2 mRNA CTD PMID:22714537 potassium chromate decreases expression ISO RGD:1348089 6480464 potassium chromate(VI) results in decreased expression of PLK2 mRNA CTD PMID:22079256 potassium cyanide decreases expression ISO RGD:733048 6480464 Potassium Cyanide results in decreased expression of PLK2 mRNA CTD PMID:33914522 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:733048 6480464 Pregnenolone Carbonitrile results in decreased expression of PLK2 mRNA CTD PMID:28903501 progesterone multiple interactions ISO RGD:1348089 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of PLK2 mRNA CTD PMID:20660070 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of PLK2 mRNA CTD PMID:20726854 propanal increases expression ISO RGD:1348089 6480464 propionaldehyde results in increased expression of PLK2 mRNA CTD PMID:26079696 propiconazole increases expression ISO RGD:733048 6480464 propiconazole results in increased expression of PLK2 mRNA CTD PMID:21278054 quercetin increases expression ISO RGD:1348089 6480464 Quercetin results in increased expression of PLK2 mRNA CTD PMID:21632981 quinolin-8-ol increases expression ISO RGD:1348089 6480464 Oxyquinoline results in increased expression of PLK2 mRNA CTD PMID:21632981 riddelliine multiple interactions ISO RGD:1348089 6480464 [CYP3A4 protein results in increased metabolism of riddelliine] which results in increased expression of PLK2 mRNA CTD PMID:33884520 SB 431542 multiple interactions ISO RGD:1348089 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:733048 6480464 Silicon Dioxide results in increased expression of PLK2 mRNA CTD PMID:19073995 more ... silicon dioxide increases expression ISO RGD:1348089 6480464 Silicon Dioxide results in increased expression of PLK2 mRNA CTD PMID:25351596 silver atom increases expression ISO RGD:1348089 6480464 Silver results in increased expression of PLK2 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1348089 6480464 Silver results in increased expression of PLK2 mRNA CTD PMID:26014281 simvastatin decreases expression ISO RGD:733048 6480464 Simvastatin results in decreased expression of PLK2 mRNA CTD PMID:19262002 sodium arsenite decreases expression ISO RGD:1348089 6480464 sodium arsenite results in decreased expression of PLK2 mRNA CTD PMID:22714537 sodium arsenite increases expression ISO RGD:1348089 6480464 sodium arsenite results in increased expression of PLK2 mRNA CTD PMID:12760830 , PMID:25266719 Soman increases expression EXP 6480464 Soman results in increased expression of PLK2 mRNA CTD PMID:19281266 sorafenib increases expression ISO RGD:1348089 6480464 sorafenib results in increased expression of PLK2 mRNA CTD PMID:26409325 succimer multiple interactions ISO RGD:733048 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLK2 mRNA CTD PMID:21641980 tamoxifen affects expression ISO RGD:733048 6480464 Tamoxifen affects the expression of PLK2 mRNA CTD PMID:17555576 , PMID:20937368 temozolomide increases expression ISO RGD:1348089 6480464 Temozolomide results in increased expression of PLK2 mRNA CTD PMID:31758290 terbufos increases methylation ISO RGD:1348089 6480464 terbufos results in increased methylation of PLK2 promoter CTD PMID:22847954 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PLK2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:733048 6480464 Carbon Tetrachloride results in decreased expression of PLK2 mRNA CTD PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PLK2 mRNA CTD PMID:31150632 tetraphene multiple interactions ISO RGD:733048 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK2 mRNA CTD PMID:27858113 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLK2 mRNA CTD PMID:33854195 thimerosal increases expression ISO RGD:1348089 6480464 Thimerosal results in increased expression of PLK2 mRNA CTD PMID:16870260 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PLK2 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression ISO RGD:733048 6480464 titanium dioxide results in increased expression of PLK2 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PLK2 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of PLK2 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:1348089 6480464 torcetrapib results in increased expression of PLK2 mRNA CTD PMID:23228038 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PLK2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1348089 6480464 trichostatin A results in increased expression of PLK2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1348089 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLK2 mRNA CTD PMID:27188386 Triptolide increases expression ISO RGD:733048 6480464 triptolide results in increased expression of PLK2 mRNA CTD PMID:32835833 triptonide increases expression ISO RGD:733048 6480464 triptonide results in increased expression of PLK2 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1348089 6480464 tris(2-butoxyethyl) phosphate affects the expression of PLK2 mRNA CTD PMID:29024780 troglitazone decreases expression ISO RGD:1348089 6480464 troglitazone results in decreased expression of PLK2 mRNA CTD PMID:19140230 , PMID:20846491 trovafloxacin increases expression ISO RGD:733048 6480464 trovafloxacin results in increased expression of PLK2 mRNA CTD PMID:35537566 urethane increases expression ISO RGD:1348089 6480464 Urethane results in increased expression of PLK2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1348089 6480464 Valproic Acid results in decreased expression of PLK2 mRNA CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1348089 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLK2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1348089 6480464 Valproic Acid results in increased expression of PLK2 mRNA CTD PMID:23179753 more ... vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of PLK2 mRNA CTD PMID:23034163 , PMID:23869203